Research and Clinical Trials
Search Cancer Clinical Trials
|Title||Pemetrexed and Carboplatin in Recurrent Platinum Sensitive Ovarian Cancer|
|Description||The purpose of this study is to determine the effects (good and bad) the combination of carboplatin and pemetrexed has on patients with recurrent ovarian, peritoneal, or fallopian tube cancer.|
|Eligibility Criteria||To be eligible for this study, patients must meet several criteria, including but not limited to the following:|
* Patient must be Female and 18 years or older
* Patient must have a histopathologically confirmed diagnosis of epithelial ovarian, primary peritoneal, or fallopian tube carcinoma.
* Patient must have a life expectancy of greater than 12 weeks.
|Principal Investigator||Dennis Kuo, MD|
|Contact Name||Loraine Centrilla, RN|
|Current Trial Type||Interventional|
|Montefiore Clinical Trial||No|
|CHAM Clinical Trial||No|